Comparing the Hemodiafiltration On-line and Conventional Hemodialysis in Terms of Cost-benefit
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.
Also called NCT02374372
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 140 participants
- Registry
-
NCT02374372
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT02374372. Randomized; no masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2015-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparing the Hemodiafiltration On-line and Conventional Hemodialysis in Terms of Cost-benefit
- Acronym
- PHARMACO-$
- Condition
- Chronic Renal Failure
- Condition
- Hemodialysis
- Intervention (Device)
- conventional hemodialysis
- Intervention (Device)
- hemodiafiltration On-line
- Lead sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
Record details
- Record id
cardio:ct-nct02374372- Content hash
dd93f0da17231fb14e4897c8fefcaca0610a159550defc078627c6528f41dbbe